Priscilla Brastianos is the lead investigator for the Alliance clinical trial ("Genetic Testing in Guiding Treatment for Patients With Brain Metastases"), which examines paxalisib and two other drugs on patients based upon genetic biomarkers.
KZA Price at posting:
$1.40 Sentiment: Buy Disclosure: Held